Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CART Treatment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchUnknownNCT04173988
What this trial is testing

Study of alloCART-19 Cell Therapy in Pediatric Patients With Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

Who this might be right for
ALL, Childhood B-Cell
Children's Hospital of Fudan University 6
Large-scale testing (Phase 3)Looking for participantsNCT04892654
What this trial is testing

Efficacy of Doravirine + Dolutegravir Dual Therapy in the Context of Antiretroviral Therapy Switch

Who this might be right for
HIV-1-infection
Chelsea and Westminster NHS Foundation Trust 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT04648280
What this trial is testing

Safety and Pharmacokinetics Evaluation of Fostemsavir + (OBT) in HIV-1 Infected Children and Adolescents Who Are Failing Their cART and Have Dual- or Triple-class Antiretroviral Resistance

Who this might be right for
HIV Infections With Multi Drug Resistant Virus
PENTA Foundation 60
Early research (Phase 1)WithdrawnNCT01316146
What this trial is testing

Administration of T Lymphocytes for Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma (CART CD30)

Who this might be right for
Non-Hodgkin's LymphomaHodgkin's Lymphoma
UNC Lineberger Comprehensive Cancer Center
Early research (Phase 1)UnknownNCT05605197
What this trial is testing

U87 CART in Treatment of Advanced Solid Tumor

Who this might be right for
Pancreatic CancerSolid Tumor, Adult
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd 12
Early research (Phase 1)Not Yet RecruitingNCT06006741
What this trial is testing

Universal CAR-T Cells Targeting Multiple Myeloma

Who this might be right for
Multiple Myeloma in Remission
Shenzhen Geno-Immune Medical Institute 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04637503
What this trial is testing

4SCAR-T Therapy Targeting GD2, PSMA and CD276 for Treating Neuroblastoma

Who this might be right for
Neuroblastoma
Shenzhen Geno-Immune Medical Institute 100
Not applicableStudy completedNCT02388828
What this trial is testing

CART-meso Long-term Follow-up

Who this might be right for
Subjects Who Have Received Lentiviral-based CART-meso Therapy
University of Pennsylvania 10
Not applicableStudy completedNCT03969550
What this trial is testing

Do CCR5 Antagonists Improve the Overall Survival of Patients With AIDS-related Progressive Multifocal Leucoencephalopathy?

Who this might be right for
AIDSProgressive Multifocal Leucoencephalopathy (PML)
Fondation Ophtalmologique Adolphe de Rothschild 34
Early research (Phase 1)Ended earlyNCT05169489
What this trial is testing

BbT369 in Relapsed and/or Refractory B Cell Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
Diffuse Large B Cell Lymphoma (DLBCL)
Regeneron Pharmaceuticals 15
Early research (Phase 1)UnknownNCT02799550
What this trial is testing

Allogeneic CART-19 for Elderly Relapsed/Refractory CD19+ ALL

Who this might be right for
Leukemia
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT05396885
What this trial is testing

Study of Anitocabtagene-autoleucel in Relapsed or Refractory Multiple Myeloma (iMMagine-1)

Who this might be right for
Multiple Myeloma
Kite, A Gilead Company 136
Very early researchNot Yet RecruitingNCT07234721
What this trial is testing

SL4903 CAR-T Therapy for Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed and Refractory Multiple Myeloma (RRMM)
Institute of Hematology & Blood Diseases Hospital, China 9
Not applicableLooking for participantsNCT04300998
What this trial is testing

Study of CAR-T Therapy in Older Patients

Who this might be right for
LymphomaRefractory B-Cell LymphomaLymphoma, B-Cell+3 more
Memorial Sloan Kettering Cancer Center 154
Early research (Phase 1)UnknownNCT02580747
What this trial is testing

Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso

Who this might be right for
Malignant MesotheliomaPancreatic CancerOvarian Tumor+3 more
Chinese PLA General Hospital 20
Not applicableStudy completedNCT05390671
What this trial is testing

CAR-T Cell Therapy in Patients With Hematological Malignancies

Who this might be right for
CART Therapy
Grupo Espanol de trasplantes hematopoyeticos y terapia celular 260
Testing effectiveness (Phase 2)UnknownNCT01935843
What this trial is testing

Treatment of Chemotherapy Refractory Human Epidermalgrowth Factor Receptor-2( HER-2) Positive Advanced Solid Tumors

Who this might be right for
Advanced HER-2 Positive Solid TumorsChemotherapy RefactoryHER-2 Antibody Inhibitor Therapy Refactory
Chinese PLA General Hospital 10
Testing effectiveness (Phase 2)Looking for participantsNCT06971380
What this trial is testing

Study of HBI0101 (NXC-201) CAR-T Therapy in Multiple Myeloma and Light-Chain Amyloidosis

Who this might be right for
Multiple Myeloma, Refractory to Standard TreatmentMultiple Myeloma, RelapsedLight Chain Amyloidosis
Polina Stepensky 180
Early research (Phase 1)Looking for participantsNCT06626919
What this trial is testing

Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

Who this might be right for
Muscular DiseasesNeuromuscular ManifestationsAutoimmune+4 more
Arcellx, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT03296553
What this trial is testing

Impact of Valganciclovir on Severe IRIS-Kaposi Sarcoma Mortality: an Open-label, Parallel, Randomized Controlled-trial.

Who this might be right for
Kaposi SarcomaHuman Immunodeficiency VirusImmune Reconstitution Syndrome
National Institute of Cancerología 40
Next Page